Bladder Cancer
FEATURED CONTENT
-
A recent review provided an update on traditional and novel risk factors for bladder cancer that may help guide prevention efforts.
-
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
-
Neoadjuvant chemotherapy response rates differed among patients with genomically unstable bladder tumors, urothelial-like bladder tumors, and basal/squamous subtypes.
-
A new algorithm developed by Canadian investigators aims to address underuse of cisplatin-based chemotherapy for muscle-invasive bladder cancer.
-
FDA label changes for certain immunotherapies may have prompted a marked increase in the use of PD-L1 assays.
BLADDER CANCER NEWS
Next post in Bladder Cancer
Loading...
Loading...